A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis
Clinical trial NCT00779220 · TERMINATED
Trial details
- NCT number
- NCT00779220
- Sponsor
- Chugai Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-02-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.